BackSummit Therapeutics Overview

Summit Therapeutics Current Assets

Summit Therapeutics's current assets is $720M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$720.58M
↑ 133.02% YoYΔ $411.34M vs prior year quarter

Peer average

Loading

Summit Therapeutics Current Assets History

Loading

Summit Therapeutics vs. peers: Current Assets Comparison

Loading

Summit Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Summit Therapeutics (SMMT) FAQ

Summit Therapeutics (SMMT) currently reports a current assets of $720M as of June 2026. That compares with $310M in the prior-year period — up 133.0% year over year. Use the charts on this page to explore Summit Therapeutics's current assets history and peer comparisons.

Summit Therapeutics's current assets increased from $310M to $720M — a 133.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Summit Therapeutics reported $720M in current assets as of June 2026. That compares with $310M in the prior-year period — up 133.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $720M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Summit Therapeutics, and consider following SMMT for alerts when major investors trade the stock.